Gonadotrophin hormone releasing analogues open new doors in cancer treatment.
作者信息
Waxman J
机构信息
Royal Postgraduate Medical School, London.
出版信息
Br Med J (Clin Res Ed). 1987 Oct 31;295(6606):1084-5. doi: 10.1136/bmj.295.6606.1084.
Abstract
摘要
相似文献
1
Gonadotrophin hormone releasing analogues open new doors in cancer treatment.促性腺激素释放类似物为癌症治疗打开了新的大门。
Br Med J (Clin Res Ed). 1987 Oct 31;295(6606):1084-5. doi: 10.1136/bmj.295.6606.1084.
2
[Treatment of carcinoma of the prostate with analogs of LHRH].
Rev Clin Esp. 1986 Nov;179(8):407-11.
3
Metastatic carcinoma of the prostate in both testes of patients treated with LH-RH analogues.接受促性腺激素释放激素（LH-RH）类似物治疗的患者双侧睾丸出现前列腺转移性癌。
Br J Urol. 1992 Jun;69(6):657-9. doi: 10.1111/j.1464-410x.1992.tb15643.x.
4
Response to D-Trp-6-luteinising hormone releasing hormone (Decapeptyl) microcapsules in advanced ovarian cancer.晚期卵巢癌对D-色氨酸-6-促黄体生成激素释放激素（曲普瑞林）微胶囊的反应
Br Med J (Clin Res Ed). 1988 Apr 30;296(6631):1229. doi: 10.1136/bmj.296.6631.1229.
5
Importance of early tumour exacerbation in patients treated with long acting analogues of gonadotrophin releasing hormone for advanced prostatic cancer.长效促性腺激素释放激素类似物治疗晚期前列腺癌患者中早期肿瘤恶化的重要性。
Br Med J (Clin Res Ed). 1985 Nov 16;291(6506):1387-8. doi: 10.1136/bmj.291.6506.1387.
6
Medical or surgical orchidectomy.药物或手术去势。
BMJ. 1991 May 25;302(6787):1272. doi: 10.1136/bmj.302.6787.1272-a.
7
8
Gonadotropin-releasing hormone analogs and prostatic cancer.促性腺激素释放激素类似物与前列腺癌
Crit Rev Oncol Hematol. 1988;8(1):1-26. doi: 10.1016/s1040-8428(88)80003-9.
9
Disease flare induced by luteinising hormone releasing hormone analogues in cancer patients.癌症患者中促黄体生成素释放激素类似物诱发的疾病发作。
Lancet. 1984 Jun 9;1(8389):1302. doi: 10.1016/s0140-6736(84)92488-7.
10
[Anti-tumor effects of GnRH analogs in gynecological cancers].[促性腺激素释放激素类似物在妇科癌症中的抗肿瘤作用]
Nihon Rinsho. 2006 Apr;64 Suppl 4:127-31.
引用本文的文献
1
Treatment of high risk Sertoli-Leydig cell tumors of the ovary using a gonadotropin releasing hormone (GnRH) analog.使用促性腺激素释放激素（GnRH）类似物治疗卵巢高危 Sertoli-Leydig 细胞肿瘤。
Pediatr Blood Cancer. 2013 Jun;60(6):E16-8. doi: 10.1002/pbc.24382. Epub 2012 Nov 28.
2
The effects of gonadotrophin releasing hormone analogues in prostate cancer are mediated through specific tumour receptors.促性腺激素释放激素类似物在前列腺癌中的作用是通过特定的肿瘤受体介导的。
Br J Cancer. 1990 Jul;62(1):96-9. doi: 10.1038/bjc.1990.236.
3
The current status of scientific research and hormonal treatments for carcinoma of the prostate.前列腺癌的科研现状及激素治疗
Br J Cancer. 1991 Sep;64(3):419-21. doi: 10.1038/bjc.1991.324.
本文引用的文献
1
The influence of hormonal therapy on survival of men with advanced prostatic cancer.激素疗法对晚期前列腺癌男性患者生存率的影响。
J Urol. 1982 Aug;128(2):335-40. doi: 10.1016/s0022-5347(17)52915-8.
2
Tumor growth inhibition in patients with prostatic carcinoma treated with luteinizing hormone-releasing hormone agonists.用促黄体生成素释放激素激动剂治疗的前列腺癌患者的肿瘤生长抑制
Proc Natl Acad Sci U S A. 1982 Mar;79(5):1658-62. doi: 10.1073/pnas.79.5.1658.
3
Treatment with gonadotrophin releasing hormone analogue in advanced prostatic cancer.促性腺激素释放激素类似物治疗晚期前列腺癌。
Br Med J (Clin Res Ed). 1983 Apr 23;286(6374):1309-12. doi: 10.1136/bmj.286.6374.1309.
4
Biodegradable polymer luteinising hormone releasing hormone analogue for prostatic cancer: use of a new peptide delivery system.用于前列腺癌的可生物降解聚合物促黄体生成素释放激素类似物：一种新型肽递送系统的应用
Br Med J (Clin Res Ed). 1984 Dec 8;289(6458):1580-1. doi: 10.1136/bmj.289.6458.1580.
5
Failure of long term luteinising hormone releasing hormone treatment for prostatic cancer to suppress serum luteinising hormone and testosterone.长期使用促黄体生成素释放激素治疗前列腺癌未能抑制血清促黄体生成素和睾酮。
Br Med J (Clin Res Ed). 1984 Aug 25;289(6443):468-9. doi: 10.1136/bmj.289.6443.468.
6
Advanced carcinoma of the prostate: treatment with a gonadotrophin releasing hormone agonist.晚期前列腺癌：用促性腺激素释放激素激动剂治疗
Br Med J (Clin Res Ed). 1983 May 21;286(6378):1607-9. doi: 10.1136/bmj.286.6378.1607.
7
Treatment with a luteinising-hormone-releasing-hormone analogue (buserelin) in premenopausal patients with metastatic breast cancer.在绝经前转移性乳腺癌患者中使用促黄体生成素释放激素类似物（布舍瑞林）进行治疗。
Lancet. 1982 May 29;1(8283):1213-6. doi: 10.1016/s0140-6736(82)92339-x.
8
Sustained suppression of testosterone production by the luteinising-hormone releasing-hormone agonist buserelin in patients with advanced prostate carcinoma. A new therapeutic approach?促黄体生成素释放激素激动剂布舍瑞林对晚期前列腺癌患者睾酮生成的持续抑制作用。一种新的治疗方法？
Lancet. 1982 May 15;1(8281):1097-9. doi: 10.1016/s0140-6736(82)92279-6.
9
Protection from cyclophosphamide-induced testicular damage with an analogue of gonadotropin-releasing hormone.使用促性腺激素释放激素类似物预防环磷酰胺诱导的睾丸损伤。
Lancet. 1981 May 23;1(8230):1132-4. doi: 10.1016/s0140-6736(81)92301-1.
10
The treatment of postmenopausal women with advanced breast cancer with buserelin.
Cancer Chemother Pharmacol. 1985;15(2):171-3. doi: 10.1007/BF00257531.
Zotero 插件